| 1 | Patients | 2.48% | |
| 2 | Cancer | 1.65% | |
| 3 | Sugar | 1.65% | |
| 4 | Results | 1.65% | |
| 5 | Blood | 1.65% | |
| 6 | ASCO | 1.65% | |
| 7 | Phase | 1.65% | |
| 8 | Urothelial | 0.83% | |
| 9 | Failure | 0.83% | |
| 10 | Clinical | 0.83% | |
| 11 | Portfolio | 0.83% | |
| 12 | Nivolumab | 0.83% | |
| 13 | Signs | 0.83% | |
| 14 | pCR | 0.83% | |
| 15 | Clinically | 0.83% | |
| 16 | Risk | 0.83% | |
| 17 | CDC | 0.83% | |
| 18 | Adenotonsillectomy | 0.83% | |
| 19 | Neoadjuvant | 0.83% | |
| 20 | Study | 0.83% | |
| 21 | Rapid | 0.83% | |
| 22 | Reviewed | 0.83% | |
| 23 | Ejection | 0.83% | |
| 24 | PET | 0.83% | |
| 25 | Natural | 0.83% | |
| 26 | Fraction | 0.83% | |
| 27 | Advanced | 0.83% | |
| 28 | Prevalence | 0.83% | |
| 29 | Systematic | 0.83% | |
| 30 | New | 0.83% | |
| 31 | Molecular | 0.83% | |
| 32 | Effusion-Synovitis | 0.83% | |
| 33 | Osteoarthritis | 0.83% | |
| 34 | ctDNA? | 0.83% | |
| 35 | Czechia | 0.83% | |
| 36 | Have | 0.83% | |
| 37 | Questions | 0.83% | |
| 38 | Perioperative | 0.83% | |
| 39 | Cisplatin-Ineligible | 0.83% | |
| 40 | (BT8009) | 0.83% | |
| 41 | Review | 0.83% | |
| 42 | Surgeries | 0.83% | |
| 43 | Sustains | 0.83% | |
| 44 | Tympanostomy | 0.83% | |
| 45 | Advantage | 0.83% | |
| 46 | School | 0.83% | |
| 47 | Nectin-4?targeting | 0.83% | |
| 48 | Pevedotin | 0.83% | |
| 49 | Preserved | 0.83% | |
| 50 | Duravelo-1 | 0.83% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||